Amylyx Pharmaceuticals, Inc. (AMLX) Shareholders’ equity 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) shareholders’ equity at each fiscal year-end, per SEC filings.
$305.3MFY2025 · since FY2021: -$151.2M → $305.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $305.3M | +85.3% |
| FY2024 | $164.8M | -62.0% |
| FY2023 | $433.4M | +27.3% |
| FY2022 | $340.6M | +325.3% |
| FY2021 | -$151.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice